Carl J. Cardella

4.4k total citations
84 papers, 3.0k citations indexed

About

Carl J. Cardella is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Carl J. Cardella has authored 84 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Transplantation, 35 papers in Surgery and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Carl J. Cardella's work include Renal Transplantation Outcomes and Treatments (48 papers), Transplantation: Methods and Outcomes (18 papers) and Organ Donation and Transplantation (15 papers). Carl J. Cardella is often cited by papers focused on Renal Transplantation Outcomes and Treatments (48 papers), Transplantation: Methods and Outcomes (18 papers) and Organ Donation and Transplantation (15 papers). Carl J. Cardella collaborates with scholars based in Canada, United States and United Kingdom. Carl J. Cardella's co-authors include Edward Cole, Daniel Cattran, Stanley Fenton, Gerald T. Cook, P.A. Davies, A. C. Allison, Daniel C. Cattran, Jeffrey S. Zaltzman, Lori J. West and David Osoba and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Carl J. Cardella

84 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl J. Cardella Canada 29 1.2k 1.2k 528 528 459 84 3.0k
Ronald H. Kerman United States 30 1.4k 1.1× 1.9k 1.6× 363 0.7× 553 1.0× 356 0.8× 131 3.3k
C Hiesse France 27 744 0.6× 958 0.8× 517 1.0× 539 1.0× 402 0.9× 122 2.4k
Giuseppe Segoloni Italy 30 1.0k 0.8× 1.1k 0.9× 393 0.7× 448 0.8× 370 0.8× 165 3.3k
Robert C. Harland United States 28 1.8k 1.5× 1.0k 0.9× 486 0.9× 303 0.6× 322 0.7× 86 3.4k
G. Offner Germany 31 790 0.6× 1.1k 1.0× 372 0.7× 706 1.3× 411 0.9× 146 2.9k
Martin S. Polinsky United States 25 763 0.6× 1.3k 1.1× 364 0.7× 309 0.6× 287 0.6× 69 2.6k
H Wilczek Sweden 32 1.1k 0.9× 1.2k 1.0× 611 1.2× 322 0.6× 328 0.7× 88 3.1k
Mark L. Jordan United States 35 1.6k 1.3× 2.2k 1.9× 753 1.4× 723 1.4× 429 0.9× 173 4.3k
J.M. Morales Spain 35 1.1k 0.9× 2.0k 1.7× 421 0.8× 511 1.0× 329 0.7× 154 3.9k
Diego Cantarovich France 29 1.4k 1.1× 2.0k 1.7× 537 1.0× 526 1.0× 270 0.6× 148 3.6k

Countries citing papers authored by Carl J. Cardella

Since Specialization
Citations

This map shows the geographic impact of Carl J. Cardella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl J. Cardella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl J. Cardella more than expected).

Fields of papers citing papers by Carl J. Cardella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl J. Cardella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl J. Cardella. The network helps show where Carl J. Cardella may publish in the future.

Co-authorship network of co-authors of Carl J. Cardella

This figure shows the co-authorship network connecting the top 25 collaborators of Carl J. Cardella. A scholar is included among the top collaborators of Carl J. Cardella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl J. Cardella. Carl J. Cardella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shehata, Nadine, Valerie A. Palda, Ralph M. Meyer, et al.. (2009). The Use of Immunoglobulin Therapy for Patients Undergoing Solid Organ Transplantation: An Evidence-Based Practice Guideline. Transfusion Medicine Reviews. 24. S7–S27. 69 indexed citations
2.
Jeloka, Tarun, Heather J. Ross, Robert Smith, et al.. (2007). Renal transplant outcome in high‐cardiovascular risk recipients. Clinical Transplantation. 21(5). 609–614. 36 indexed citations
4.
Prasad, G. V. Ramesh, S. Joseph Kim, Michael Huang, et al.. (2004). Reduced Incidence of New-Onset Diabetes Mellitus after Renal Transplantation with 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors (Statins). American Journal of Transplantation. 4(11). 1897–1903. 43 indexed citations
5.
Cardella, Carl J., Daniel C. Cattran, S. Fenton, et al.. (2001). Optimization of cyclosporine exposure utilizing C2 level monitoring in de novo renal transplant recipients: the toronto general hospital experience. Transplantation Proceedings. 33(7-8). 3098–3099. 24 indexed citations
6.
Karpinski, Jolanta, Ginette Lajoie, Daniel C. Cattran, et al.. (1999). OUTCOME OF KIDNEY TRANSPLANTATION FROM HIGH-RISK DONORS IS DETERMINED BY BOTH STRUCTURE AND FUNCTION. Transplantation. 67(8). 1162–1167. 181 indexed citations
7.
Abbey, Susan, Gerald M. Devins, Christine Littlefield, et al.. (1998). ILLNESS INTRUSIVENESS & TRANSPLANTATION. Psychosomatic Medicine. 60(1). 113–113. 5 indexed citations
8.
Cole, Edward, Daniel Cattran, Vernon T. Farewell, et al.. (1994). A COMPARISON OF RABBIT ANTITHYMOCYTE SERUM ANE OKT3 AS PROPHYLAXIS AGAINST RENAL ALLOGRAFT REJECTION. Transplantation. 57(1). 60–67. 41 indexed citations
9.
Fyfe, Alistair I., et al.. (1993). Coronary sinus sampling of cytokines after heart transplantation: Evidence for macrophage activation and interleukin-4 production within the graft. Journal of the American College of Cardiology. 21(1). 171–176. 41 indexed citations
10.
Cardella, Carl J.. (1991). The use of the kidney with an historical positive, and current negative crossmatch. Pediatric Nephrology. 5(1). 126–129. 5 indexed citations
11.
Brady, Hugh R., et al.. (1990). Low Dose Ciclosporin from the Early Postoperative Period Yields Potent Immunosuppression after Renal Transplantation. ˜The œNephron journals/Nephron journals. 55(4). 394–399. 2 indexed citations
12.
Roy, Louise, et al.. (1989). Short-term effects of calcium antagonists on hemodynamics and cyclosporine pharmacokinetics in heart-transplant and kidney-transplant patients. Clinical Pharmacology & Therapeutics. 46(6). 657–667. 9 indexed citations
13.
Cattran, Daniel, Terry Delmore, Janet Roscoe, et al.. (1989). A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous Nephropathy. New England Journal of Medicine. 320(4). 210–215. 158 indexed citations
14.
Blake, Peter G. & Carl J. Cardella. (1989). Kidney donation by living unrelated donors.. PubMed. 141(8). 773–5. 3 indexed citations
15.
Dorian, Paul, et al.. (1988). Digoxin-cyclosporine interaction: severe digitalis toxicity after cyclosporine treatment.. PubMed. 11(2). 108–12. 37 indexed citations
16.
Dorian, Paul, et al.. (1987). Cyclosporine nephrotoxicity and cyclosporine--digoxin interaction prior to heart transplantation.. PubMed. 19(1 Pt 2). 1825–7. 6 indexed citations
17.
Gupta, Aditya K., Madhulika A. Gupta, Carl J. Cardella, & Herbert F. Haberman. (1986). Cutaneous Associations of Chronic Renal Failure and Dialysis. International Journal of Dermatology. 25(8). 498–504. 44 indexed citations
18.
Cardella, Carl J.. (1985). Plasma exchange and renal transplantation. Journal of Clinical Apheresis. 2(4). 405–409. 4 indexed citations
19.
Landsberg, David, et al.. (1985). IN VITRO IMMUNOGLOBULIN PRODUCTION IN LONG-TERM RENAL TRANSPLANT RECIPIENTS. Transplantation. 39(4). 389–392. 4 indexed citations
20.
Cattran, Daniel, et al.. (1985). Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney International. 27(2). 436–441. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026